Novartis Ag Adr Stock Market Value

NVS Stock  USD 96.73  0.85  0.89%   
Novartis' market value is the price at which a share of Novartis trades on a public exchange. It measures the collective expectations of Novartis AG ADR investors about its performance. Novartis is selling for under 96.73 as of the 28th of March 2024; that is 0.89 percent increase since the beginning of the trading day. The stock's lowest day price was 96.15.
With this module, you can estimate the performance of a buy and hold strategy of Novartis AG ADR and determine expected loss or profit from investing in Novartis over a given investment horizon. Check out Novartis Correlation, Novartis Volatility and Novartis Alpha and Beta module to complement your research on Novartis.
Symbol

Novartis AG ADR Price To Book Ratio

Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.987
Dividend Share
3.919
Earnings Share
4.1
Revenue Per Share
22.467
Quarterly Revenue Growth
0.074
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Novartis 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novartis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novartis.
0.00
02/27/2024
No Change 0.00  0.0 
In 31 days
03/28/2024
0.00
If you would invest  0.00  in Novartis on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Novartis AG ADR or generate 0.0% return on investment in Novartis over 30 days. Novartis is related to or competes with Madrigal Pharmaceuticals, 23Andme Holding, Moleculin Biotech, Equillium, Mustang Bio, Seres Therapeutics, and Agilent Technologies. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide More

Novartis Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novartis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novartis AG ADR upside and downside potential and time the market with a certain degree of confidence.

Novartis Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Novartis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novartis' standard deviation. In reality, there are many statistical measures that can use Novartis historical prices to predict the future Novartis' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
94.7895.8696.94
Details
Intrinsic
Valuation
LowRealHigh
86.29105.31106.39
Details
Naive
Forecast
LowNextHigh
92.8193.8894.96
Details
12 Analysts
Consensus
LowTargetHigh
102.60112.75125.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Novartis. Your research has to be compared to or analyzed against Novartis' peers to derive any actionable benefits. When done correctly, Novartis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Novartis AG ADR.

Novartis AG ADR Backtested Returns

Novartis AG ADR has Sharpe Ratio of -0.0028, which conveys that the firm had a -0.0028% return per unit of risk over the last 3 months. Novartis exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novartis' Mean Deviation of 0.7231, risk adjusted performance of 0.0193, and Downside Deviation of 1.1 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novartis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Novartis is expected to be smaller as well. Novartis AG ADR has an expected return of -0.003%. Please make sure to verify Novartis AG ADR sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if Novartis AG ADR performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.4  

Poor reverse predictability

Novartis AG ADR has poor reverse predictability. Overlapping area represents the amount of predictability between Novartis time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novartis AG ADR price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Novartis price fluctuation can be explain by its past prices.
Correlation Coefficient-0.4
Spearman Rank Test-0.13
Residual Average0.0
Price Variance1.07

Novartis AG ADR lagged returns against current returns

Autocorrelation, which is Novartis stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novartis' stock expected returns. We can calculate the autocorrelation of Novartis returns to help us make a trade decision. For example, suppose you find that Novartis has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Novartis regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novartis stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novartis stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novartis stock over time.
   Current vs Lagged Prices   
       Timeline  

Novartis Lagged Returns

When evaluating Novartis' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novartis stock have on its future price. Novartis autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novartis autocorrelation shows the relationship between Novartis stock current value and its past values and can show if there is a momentum factor associated with investing in Novartis AG ADR.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Novartis AG ADR is a strong investment it is important to analyze Novartis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novartis' future performance. For an informed investment choice regarding Novartis Stock, refer to the following important reports:
Check out Novartis Correlation, Novartis Volatility and Novartis Alpha and Beta module to complement your research on Novartis.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Novartis Stock analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novartis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novartis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...